Clinical Trial Update: Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing sugammadex with neostigmine/atropine for reversing neuromuscular block in obstructive sleep apnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Atropine (atropine)
• Neostigmine (neostigmine)
• Sugammadex (sugammadex)

Snippet

Sponsor: Diskapi Teaching and Research Hospital | Conditions: Obstructive Sleep Apnea | Phase 4 | Status: COMPLETED